LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA

Clinical trials for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat stomach cancers: experimental combo enters Mid-Stage testing

Disease control Recruiting now

This study is testing a new combination of drugs for adults with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery. Researchers want to find the safest and most effective dose of an experimental drug (telisotuzumab adizutecan) whe…

Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA

Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA

Get alerted when new LOCALLY ADVANCED UNRESECTABLE OR METASTATIC GASTRIC ADENOCARCINOMA trials appear

New hope for Tough-to-Treat stomach cancers: experimental combo enters Mid-Stage testing